Scientists at UCL and GOSH have used groundbreaking base-edited CAR‑T cell therapy — BE‑CAR7 — to treat aggressive T‑cell leukaemia, with two‑thirds of patients now disease‑free.
Pascale V Guillot, Associate Professor at University College London, investigates the possibility of exosome therapy for those living with brittle bone disease.
First patient-derived stem cell model for studying eye conditions related to oculocutaneous albinism developed by the National Eye Institute
Lead author of the report, Doctor...
Researching DNA outside of our genes, analysing the ‘dark genome’, scientists have found evolved proteins which can distinguish between schizophrenia and bipolar disorders, improving diagnosis and treatment.
Professor Olivier Braissant, believes there is hope for the treatment of creatine deficiency thanks to new genetic disease research - here, he tells us all about the recent developments.
In toxicology & health science focus, Ken Tachibana, Sanyo-Onoda City University in Japan, walks through the long-term effects of exposure to nanoparticles
L. Val Giddings, PhD, Senior Fellow, Information Technology and Innovation Foundation, states that gene editing promises to make human industry sustainable*.
